论文部分内容阅读
目的:比较甲型流感与发热上呼吸道感染的早期鉴别诊断、治疗。方法:纳入64例甲型流感(A组)、发热上呼吸道感染(B组)患者,从一般资料、流行病学、临床症状、实验室检查、治疗、预后等分析。A组给予磷酸奥司他韦胶囊,中医辨证治疗;B组给予西菝常规治疗加中医常用方。结果:A组接触史高于B组,A组患者上呼吸道感染症状较B组明显,2组患者均无皮疹。A组血白细胞(WBC)、中性粒细胞(NEUT)、血小板(BPC)低于B组,2组比较,差异有统计学意义(P<0.05)。总有效率A组93.75%,B组100%,2组临床疗效比较,差异无统计学意义(P=0.151)。结论:发热患者常规行血常规检查,血象低者需进一步行甲型/乙型流感病毒抗体检测,流感患者需进一步完善胸片;治疗上应尽早规范口服奥司他韦,结合中药辨治常获良效。
Objective: To compare the early diagnosis and treatment of influenza A and febrile upper respiratory tract infection. Methods: A total of 64 patients with influenza A (A) and upper respiratory tract infection (B) were enrolled in this study. General information, epidemiology, clinical symptoms, laboratory tests, treatment and prognosis were included. A group given oseltamivir phosphate capsules, traditional Chinese medicine syndrome differentiation; B group given conventional treatment of Western medicine and Chinese medicine commonly used side. Results: The contact history in group A was higher than that in group B. The symptoms of upper respiratory tract infection in group A were more obvious than those in group B, and no rash occurred in both groups. A group of white blood cells (WBC), neutrophils (NEUT), platelet (BPC) lower than the B group, the two groups, the difference was statistically significant (P <0.05). The total effective rate was 93.75% in group A and 100% in group B, and there was no significant difference in clinical efficacy between the two groups (P = 0.151). CONCLUSIONS: Fever patients routinely perform routine blood tests, and those with low blood counts need further tests to detect influenza A / B antibodies. Patients with influenza should further improve their chest radiographs. Treatment should be standardized oral oseltamivir, combined with traditional Chinese medicine Be good.